At the inquiry
Qualified leads
Claimants screened against your firm’s hair relaxer criteria, delivered with their responses to your intake team or CRM.
For teams that handle follow-up and conversion.
Discuss qualified leadsClaims allege that long-term use of chemical hair relaxers and straighteners caused uterine cancer and other conditions. We screen claimants against your firm’s criteria, with an intake process built for sensitive health histories.
Discuss a campaignSummary of public information for law firms. Not legal advice.
Delivery models
The right model depends on your intake capacity and acquisition economics.
At the inquiry
Claimants screened against your firm’s hair relaxer criteria, delivered with their responses to your intake team or CRM.
For teams that handle follow-up and conversion.
Discuss qualified leadsAt the conversation
Screened claimants connected directly with your intake team during agreed hours and within your delivery caps.
For teams ready to take a live call.
How live transfers workAt the retainer
For select programs, acquisition structured around qualified, completed e-signed retainers.
For firms seeking a retained-client model.
About retainer programsThe litigation · October 2026
Litigation moves quickly. We confirm current status, and whether a program fits your firm’s strategy, before launch.
SourcesAn NIH study of 33,947 women found that frequent users of hair straightening products (more than four times in the prior year) were more than twice as likely to develop uterine cancer as non-users.
Federal cases were centralized as In re: Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation in the Northern District of Illinois.
Bellwether selection and expert motions continued in 2026. As of our October 2026 review, no trial or global settlement had occurred.
Screening
These are the areas hair relaxer screening typically covers. The exact questions and thresholds come from your firm.
Talk through your criteriaWhich relaxers or straighteners were used, how often and for how many years.
Uterine or endometrial cancer, or other conditions your firm accepts, and the date of diagnosis.
Treatment such as hysterectomy, and the records available.
Whether the claimant already has an attorney for the claim.
Questions
Answers specific to your program are part of the first conversation.
A 2022 NIH Sister Study analysis found frequent users of hair straightening products had more than twice the risk of uterine cancer compared with non-users. Causation is contested in the litigation.
Yes. As of October 2026, MDL No. 3060 was in pretrial proceedings before Judge Mary M. Rowland, with no global settlement announced.
Where a program requires it, leads can be delivered with a TrustedForm or Jornaya certificate. Call recordings for transfers depend on program support and applicable consent requirements.
Sources
Summary of public information as of October 2026, for law firms evaluating case acquisition. It is not legal advice, and litigation status changes.
Other torts
Start a conversation
Send the practice area, criteria and volume you have in mind. We’ll talk through the right delivery model and a sensible starting point.
Book a 30-minute intro call